Selective malabsorption of vitamin B12 without proteinuria or structural renal tract anomaly
The first reports by Imerslund' and Grasbeck2 of children presenting with a megaloblastic anaemia due to vitamin B1 2 deficiency but with normal gastric intrinsic factor activity (Imerslund-Grasbeck syndrome or selective malabsorption of vitamin BI 2) described associated proteinuria. In a review of 49 patients who had been examined for proteinuria, Visakorpi and Furuhjelm' showed that 44 patients had persistent proteinuria. Urography in 40 of these patients showed a structural anomaly of the renal tract in eight. Here we describe another child with selective malabsorption of vitamin B,1 in whom there was no proteinuria and in whom no renal tract anomaly was shown on urography.
Case report
A 3 2-year-old boy whose health had been normal until the age of 2 years presented with an 18-month history of difficult behaviour and tiring easily. He had had no abnormality of his faeces, and there was no history of consanguinity. His weight was 15 kg (between 25th and 50th percentile for his age). He was pale and irritable. There was no enlargement of the liver or spleen.
The results of preliminary investigations are shown in the table. The blood film showed anisopoikilocytosis, with oval macrocytes and neutrophil hypersegmentation. A bone marrow aspirate showed definite megaloblastic erythropoiesis and numerous giant metamyelocytes. There was increased stainable iron in the reticuloendothelial cells and in the erythroblasts. A urine sample taken without previous valine loading disclosed a methylmalonic acid concentration of 1-5 g/l. Consequently, daily physiological doses of one microgram hydroxocobalamin were given, and a reticulocyte response of 26 was noted on the fourth day. The one-hour gastric secretion after pentagastrin stimulation (6 ,tg/kg) was 30 ml, with pH 1 0, free acid 9 mmol (mEq) 1, total acid 16 4 mmol(mEq),ll, intrinsic factor activity before pentagastrin 17 U/ml, after pentagastrin 36 U,ml. The Schilling test showed impaired vitamin B1.2 absorption with less than I excretion of a l-,ug 51Co-labelled oral dose in 24 hours, and this was uncorrected by the administration of an active preparation of hog intrinsic factor. A 24-hour urine collection showed no protein even after concentration and no abnormality on amino-acid chromatography. The results of the following investigations were normal: chest x-ray film, intravenous pyelogram, barium follow-through; serum calcium and phosphate, magnesium, and vitamin A concentrations; prothrombin time; urinary indican; and tests for ova and cysts in the faeces.
After an initial loading with hydroxocobalamin he was maintained on 1000-microgram hydroxocobalamin at three-monthly intervals. All test results became normal and his weight had risen to the 90th percentile one year after treatment was commenced. 1 tmol/lz 0 06 mg, 100 ml.
Results of investigations

Discussion
The diagnosis of specific malabsorption of vitamin B12 was confirmed by the low vitamin B 12 concentration, the impaired absorption of vitamin B12, and the failure of the Schilling test to correct with intrinsic factor; the presence of normal gastric acid and intrinsic factor; and the absence of serum parietal cell and intrinsic factor antibodies. The complete response to vitamin B 12; the lack of steatorrhoea; the normal barium follow-through result; serum folate, calcium, phosphate, magnesium, and vitamin A concentrations; and prothrombin time rendered the possibility of a more general malabsorption syndrome (as in the case of Bell et a14) improbable, and jejunal biopsy was considered unjustified. There was no evidence of fishtapeworm infestation.
This patient represents a new case of selective malabsorption of B, without proteinuria. The fault is thought to be in the ileal transport of sl21 ileal receptors for intrinsic factor being present in the one patient so tested. Most doctors are especially cautious about administering drugs to a patient who is pregnant. Nevertheless, the non-gravid woman who is endeavouring to conceive or having unprotected intercourse is easily overlooked when it comes to such discriminative prescribing. One form of treatment that merits careful consideration in relation to this latter group of patients is that of prolonged tetracycline therapy for acne vulgaris. The problem with this medication is that if such a patient conceives she may continue tetracycline from six to eight weeks or even longer into her pregnancy.' We report such a case and the subsequent delivery of a malformed baby.
Case report
A 33-year-old primigravida, married for eight years without conceiving, became pregnant while taking the tetracycline, clomocycline sodium, 170-340 mg daily, and this treatment was maintained for eight weeks after her last period. The patient's menstrual cycle had sometimes been irregular, but early clinical assessments of uterine size were commensurate with a diagnosis of pregnancy dating from her last menstrual period. She had been in contact with rubella at 16 weeks, but her seronegative status, which was shown by antibody tests, was not converted by this apparent exposure.
The infant, a live boy, weighed only 1928 g at birth and showed multiple abnormalities. He had low set ears, prominent epichanthic folds, and micrognathia with mandibular hypoplasia. Deformity of both scapulae was demonstrated radiologically. Generalised contraction of the joints in flexion (arthrogryposis) was present with deficient muscle development. The fingers of both hands showed abnormal flexion of the metacarpophalangeal joints and extension of the interphalangeal joints with the second finger overlapping the third finger of the left hand. Cardiomegaly, genital hypoplasia, and severe club feet completed the anomalies. The baby died, aged 14 days, from respiratory complications. Analysis of the baby's chromosomes by gross morphology was normal, but detailed analysis by special banding techniques was not possible on the specimen received. Parental chromosome analysis was normal.
Comment
There are few reports2 of malformations in the human fetus attributable to tetracycline, but consideration of several clinical and experimental observations must engender fears of possible human teratogenesis. Tetracycline is a general inhibitor of cell metabolism and has even been employed in cancer chemotherapy.
